companydata.dkBioLean ApS: Financial statements 2022
CVR: 41078219
BioLean ApS (CVR 41078219) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,616,661 and a net result of DKK 63,671 compared with DKK -212,027 the year before. That is a decrease of 9.4% compared with the year before. Equity amounted to DKK 127,342. The solvency ratio was 11%. The company had 2 employees in the financial year.
- Gross Profit
- 1,616,661 kr.
- Profit/Loss
- 63,671 kr.
- Equity
- 127,342 kr.
- Total Assets
- 1,155,915 kr.
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 1.6 mio. | 64 t. | 127 t. | 2 |
| 2021 | - | 1.8 mio. | -212 t. | 64 t. | 4 |
| 2020 | - | 629 t. | 176 t. | 276 t. | 1 |
Keep an eye on BioLean ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
BioLean ApS has published its annual report for 2021. Gross profit came to DKK 1,783,494, and the net result was DKK -212,027.
As of February 7, 2022, Isuru Sampath Bandara Abeykoon Udugama has stepped down as director of BioLean ApS.
As of February 7, 2022, Maciej Jan Korzepa is registered as an owner of BioLean ApS with an ownership share of 15%.
About BioLean ApS
BioLean ApS is a Danish company of the type Anpartsselskab based in Gørlev, founded in 2020. The company is registered under the industry Computerprogrammering. The management consists of Jesper Bryde-Jacobsen, Laurent Jan Vermue and Maciej Jan Korzepa. The company's owners include Laurent Jan Vermue, Maciej Jan Korzepa and Tomasz Grzegorz Nowak. In 2025, the company reported a gross profit of DKK 1,226,619 and a net result of DKK -11,923 compared with DKK 6,782 the year before. Equity amounted to DKK 354,328.